Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo

Journal:

Cell

Published:

2025-07-10

DOI:

10.1016/j.cell.2025.06.023

Affiliations:

7

Authors:

20

Go to article

Institutions	Authors	Share
Walter and Eliza Hall Institute of Medical Research (WEHI), Australia	9.666667	0.48
The University of Melbourne (UniMelb), Australia	6.333333	0.32
The Peter Doherty Institute for Infection and Immunity (Doherty Institute), Australia	3.333333	0.17
Mater Research Institute - University of Queensland (MRI-UQ), Australia	0.333333	0.02
UCB Inc., United States of America (USA)	0.333333	0.02

Interested in Clinical Sciences?